Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Kazmaier Gerrit SPresident, Prod. and Tech. | Open-market sale · 10b5-1 plan | SELL | $200K 1,388 sh | Jul 7, 2026 traded Jul 7, 2026 | |
Kazmaier Gerrit SPresident, Prod. and Tech. |
Open-market sale · 10b5-1 plan |
| SELL |
| $149K 1,040 sh |
| Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $80K 593 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $63K 460 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Eltoukhy AdamSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $135K 3,653 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $114K 869 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 4 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $261K 7,163 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 4 | Abrahamsen Danielle NicoleChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $38K 254 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 3 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $9,453 73 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 3 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $38K 282 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 3 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $48K 345 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 3 | Kazmaier Gerrit SPresident, Prod. and Tech. | Open-market sale · 10b5-1 plan | SELL | $43K 300 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 1 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $35K 2,547 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 35 | Moore Daniel WilliamPFO and PAO | Open-market sale | SELL | $159K 7,085 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 30 | Kleinerman ChristianEVP, Product Management | Open-market sale · 10b5-1 plan | SELL | $646K 2,500 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 28 | Freeman Sean ClintonEVP, Strategy & Corp Devt | Open-market sale | SELL | $114K 918 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 27 | Dube Michael PVP, Chief Accounting Officer | Open-market sale | SELL | $44K 2,641 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 24 | Ford Russell WayneDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.21M 40.0K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 23 | Yaacobi TalDirector | Open-market sale | SELL | $3,108 1,400 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 22 | Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR Off | Open-market sale · 10b5-1 plan | SELL | $72K 10.9K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 21 | Harris Robert E.SVP & Chief Accounting Oficer | Open-market sale | SELL | $7,191 442 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 21 | Ding YongbiaoCFO | Open-market sale | SELL | $9,000 10.0K sh | Jul 6, 2026 traded Jul 6, 2026 |
| 21 | Wittmann MichaelChief Operating Officer | Open-market sale | SELL | $134K 30.2K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 19 | Robinson Mark HaymondGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $159K 7,083 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 17 | Stojanovic DanijelaInterim CFO | Open-market sale | SELL | $37K 8,438 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 17 | Johnson Nancy JoAnnSee Remarks | Open-market sale · 10b5-1 plan | SELL | $100K 801 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 16 | Renfroe Sean GGENERAL COUNSEL | Open-market sale · 10b5-1 plan | SELL | $82K 426 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 15 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $710K 2,600 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Hancock MarkDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $274K 6,080 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Lewis Michelle ReneeChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $189K 4,200 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Graff Marc D.SVP & Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $59K 126 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 14 | Ford Russell WayneDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.21M 40.0K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 14 | Sehmi HarminderChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $56K 40.6K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 13 | Roth James MChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $62K 20.8K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 12 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $82K 300 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 12 | Hancock MarkDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $6.44M 142.2K sh | Jul 6, 2026 traded Jul 6, 2026 |
| 12 | Lewis Michelle ReneeChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $300K 6,663 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 12 | Lin MarkEVP and CFO | Open-market sale · 10b5-1 plan | SELL | $146K 970 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 10 | Reardon AndrewCLO & Secretary | Open-market sale · 10b5-1 plan | SELL | $349K 1,119 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 10 | Reardon AndrewCLO & Secretary | Open-market sale · 10b5-1 plan | SELL | $284K 900 sh | Jul 6, 2026 traded Jul 1, 2026 |